Alle Fälle anzeigen
UPC APP 68359/2024
—·EP4111949: TRANSCUTANEOUS ANALYTE SENSORS, APPLICATORS THEREFOR, AND NEEDLE HUB COMPRISING ANTI-ROTATION FEATURE
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieRücknahmeanträge
- Parteien
- Beklagte
- Abbott Laboratories
- Abbott Diabetes Care Inc.
- Abbott GmbH
- Abbott Diagnostics GmbH
- Abbott Laboratories GmbH
- Abbott Logistics B.V.
- Abbott France (S.A.S.)
- Abbott s.r.l.
- Abbott Gesellschaft m.b.H.
- Abbott B.V.
- Abbott (S.A./N.V.)
- Abbott Scandinavia Aktiebolag
- Abbott Oy
Vertreter: Dietrich Burkhard Kamlah (Taylor Wessing) - Division
- Munich LD
- Richter
- Ulrike Voß · Presiding judge and judge-rapporteur
- Daniel Voss · Legally qualified judge
- Petri Rinkinen · Legally qualified judge
- Claus Elmeros · Technically qualified judge
- Technology
- Pharmaceutical & Medical
- Sprache
- —
- Erste Entscheidung
- 10. Jan. 2025
Entscheidungen
- 2025-01-10ZurückgenommenApplication Rop 265
Decision of the Munich Local Division permitting withdrawal of the infringement action by Dexcom Inc. against Abbott Laboratories and multiple Abbott entities, and withdrawal of the counterclaim for revocation and patent amendment application by the defendants. All parties mutually consented to withdrawal prior to the final decision date. Each party bears its own costs.
Rechtsfragen:Withdrawal of infringement action Rule 265 RoPMutual withdrawal of counterclaim for revocationWithdrawal of application to amend patentCosts upon withdrawal
Dokumente
- 4F645DE19520EF7E408D5F3A8CCFA9DB_en.pdf2025-01-10EN